CPR Pharma Services (‘CPR’) is a full-service CRO with an international reputation for delivering superior clinical trial results in Australia, New Zealand and Asia through its “Fast2PhaseOne” and “Access2Asia” services.
As the premier provider of early phase clinical trial services in the Asia-Pacific region for over a decade, CPR has leveraged its extensive experience to now offer an expanded range of services. CPR provides services to:
- Get trials underway quickly and cost effectively via Fast2PhaseOne service
- Confidently navigate entry into the Asian market via Access2Asia service
- Provide bio analytical support in the Asia-Pacific via its FDA-inspected laboratory in Australia
- Access the Australian Government’s attractive R&D Tax Incentive through its strategic partnership with one of Australia’s leading taxation experts
- Get trials back on track through its Recovery Centre.